Allotment of 57,709 Equity Shares under Mankind Employee Stock Option Plan 2022
Awaiting price reaction for this filing.
Mankind Pharma has allotted 57,709 equity shares to eligible employees who exercised their stock options under the Mankind ESOP Plan 2022. The shares have a face value of Re. 1 each and were allotted at an exercise price of Rs. 860 per share (premium of Rs. 859). As a result, the company's paid-up share capital increased from 41,26,71,039 to 41,27,28,748 equity shares. The newly allotted shares will rank equally with existing equity shares. The allotment was approved by the Nomination and Remuneration Committee on June 10, 2025.
This is a routine ESOP allotment with a very small dilution (about 0.014% increase in share count), so it is unlikely to have any material impact on the stock price or shareholder value. It reflects the company continuing to honour its employee incentive programme as planned.